GreenLab is a biotechnology company that uses a proprietary corn-based expression platform to scale the sustainable production of recombinant proteins and enzymes for the food, energy, pharmaceutical, and industrial sectors.
GreenLab is a biotechnology company that has developed a proprietary platform, known as the GreenLab Vector Technology (GVT) platform, which utilizes corn as a high-yield, scalable system for the expression of recombinant proteins and enzymes. By leveraging traditional agricultural farming practices without requiring agronomic or mechanical changes, the company transforms cornfields into efficient manufacturing sites for next-generation proteins. This approach offers a sustainable alternative to traditional biomanufacturing methods like precision fermentation, enabling the production of high-value proteins—such as brazzein, a high-intensity sweetener—at a commercial scale with reduced inputs and significant scalability.
The platform addresses critical production bottlenecks in protein design and enzyme engineering, offering partners a path to market for sustainable ingredients in the food, energy, industrial, and pharmaceutical sectors. By integrating proprietary protein expression systems into corn, GreenLab helps companies optimize production costs and environmental impact, providing an end-to-end manufacturing solution. The company actively collaborates with industry partners, such as AI-driven ingredient discovery firms, to scale the production of novel functional proteins for CPG markets and beyond, demonstrating the commercial viability of its plant-based expression system.